Загрузка...
Multifaceted antitumor responses to activating anti-CD40 antibody therapy combined with immunomodulatory or targeted agents
Therapeutic targeting of the CD40 pathway may be efficacious for cancer treatment. Accumulating evidence suggests synergistic and unique antitumor responses may be achieved using CD40-based therapies in combination with other immunomodulators or targeted agents.
Сохранить в:
| Опубликовано в: : | Oncoimmunology |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292511/ https://ncbi.nlm.nih.gov/pubmed/25610748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.954483 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|